136.90M
Market cap
Current P/E
117.65x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U. N. agencies, nonprofit organizations, and commercial partners.

Similar securities

Based on sector and market capitalization

Report issue